For research use only. Not for human consumption. Not medical advice — consult a licensed clinician.

Immune Modulator

Thymulin

Also known as: Facteur Thymique Serique (FTS)

Thymulin is a zinc-dependent nonapeptide (pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) secreted by thymic epithelial cells, originally isolated by Bach and colleagues in the 1970s as 'facteur thymique sérique' (FTS). It is NOT the same compound as Thymalin (a Russian bovine thymus extract) or Thymosin alpha-1 (a separate 28-amino-acid thymic peptide). Thymulin is not FDA-approved; use is research/investigational only.

Where to buy · live market data

Who's worth your money for Thymulin

Every current seller, ranked by independent evidence — Merit Score, latest COA purity, and live $/mg (size-normalized). Prices refresh daily. Rankings are never paid.

Top Merit pick

Highest Merit Score (96) of 1 scored sellers

$6.50/mg

$64.97 · 10mg · 99.7% purity

1 COA
Buy code MERIT · 15% off

Average price

$5.97/mg

Sellers

9

45-day trend

+3.2%

5 of 9 sellers have a current price· 1 stale hidden· 3 unverified hidden

Prices observed from public storefronts (last 24h), normalized to $/mg. "Evidence" is Merit's 0–100 Merit Score, derived only from observable verification evidence (methodology on /about); "Purity" is the latest independent COA. Some buy links are affiliate links — Merit may earn a commission at no extra cost to you, and where a vendor offers one, the code shown gets you a discount at their checkout. Affiliate status never affects price data, ranking, or the Merit Score (full policy on /disclosure). Research use only.

Watch Thymulin

Get one email when the market actually moves — no newsletter, no noise.

Compound reference

About Thymulin

CAS

78922-62-0

Molecular formula

C33H54N12O15

Sequence

pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn

Typical dose range

10–20 mcg/day subcutaneous (research use); some protocols report 100–400 mcg 3×/week

Half-life

~10 minutes (free form in vivo)

Research depth

13 citations indexed for Thymulin

All research on Thymulin →

Study · 2026

Thymulin restrains age-associated myeloid inflammation and enhances cancer immunotherapy

Chronic inflammation increases with age and contributes to cancer progression and therapeutic resistance, yet the mechanisms underlying this process remain incompletely understood.

review · 2026

Targeting Leukopoiesis: Pharmacological and Biotechnological Strategies for the Treatment of Leukopenia

Leukopenia remains a major clinical challenge associated with infectious diseases, oncological therapies, autoimmune disorders, and metabolic and iatrogenic conditions.

Study · 2026

ANP32E drives lung adenocarcinoma progression via GSK3β-mediated glycolytic reprogramming

Lung adenocarcinoma (LUAD), a leading cause of cancer mortality, involves incompletely understood epigenetic-metabolic crosstalk. We identified ANP32E as a key regulator through multi-omics (TCGA, scRNA-seq) and clinical analyses, finding its overexpression correlates with poor prognosis.

review · 2025

Maternal Thymus Adaptations and Hormone Regulation During Pregnancy

The thymus is necessary for the development of T lymphocytes and central tolerance, and adaptations in the maternal thymus are required during pregnancy. In the present paper, maternal thymic cellular anatomy, T-cell development in the thymus, and related progress are reviewed.

review · 2025

Zinc Fortification and Supplementation to Reduce Diarrhea in Children: A Literature Review

Background Zinc deficiency is a major global health issue and appears to be responsible for risk of diarrhea and death, particularly in children under 5 years. This review therefore aimed to summarize the existing literature related to zinc supplementation and fortification for the prevention of diarrhea.

animal · 2024

Systemic thymulin overexpression mitigates cognitive and molecular impairments in a rat model of sporadic Alzheimer’s Disease